Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial

Issa F. Khouri, Kamal Alzahrani, Hagop Kantarjian, Denái R. Milton, Alison M. Gulbis, Koji Sasaki, Nitin Jain, Nicholas J. Short, Tapan Kadia, May Daher, Hind Rafei, Jin S. Im, David Marin, Amanda L. Olson, Uday Popat, Muzaffar Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer Srour, Partow KebriaeiElizabeth Shpall, Richard Champlin, Elias J. Jabbour

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science